• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Archives for May 2017

Coordinated Global Solution Needed To Ensure Universal Vaccine Supply, Speakers Say

19/05/2017 by Elise De Geyter for Intellectual Property Watch Leave a Comment

Shortages of vaccines are a worldwide problem with tremendous impact on health, affecting countries of all income groups and regions, speakers said at a recent industry event. Different possible solutions for shortages of vaccines were suggested during the panel discussion.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Europe, Health & IP, Health Policy Watch, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, WHO

WIPO And The SDGs: Differing Views At Committee On IP And Development

19/05/2017 by Catherine Saez, Intellectual Property Watch 3 Comments

The World Intellectual Property Organization, as a United Nations specialised agency, has a role to play in the implementation of the UN Sustainable Development Goals (SDGs) for the year 2030. How that might happen, and which goals the organisation should pursue are a matter of ongoing discussion at the WIPO Committee on Development and Intellectual Property this week. Views diverge on whether the 17 SDGs should be considered as a whole, of if the organisation should focus on what is considered as its particular expertise and mission.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WIPO

G20 Health Ministers Receive Flurry Of Requests Ahead Of Their First-Ever Meeting

18/05/2017 by Monika Ermert for Intellectual Property Watch Leave a Comment

Civil society organisations and the Business 20 Dialogue all put their positions on the table before the opening of the first-ever meeting of G20 Health Ministers tomorrow in Berlin, Germany taking place tomorrow.

Filed Under: IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Health Policy Watch, Lobbying, Other International Orgs, Patents/Designs/Trade Secrets, Regional Policy

EU Parliament Approves Cross-Border Online Paid Content

18/05/2017 by Intellectual Property Watch Leave a Comment

The European Parliament today adopted the Portability Regulation by a margin of 586 to 34 votes with 6 abstentions. The new EU regulation will allow the cross-border use of online paid content which so far was hampered by geoblocking. Users now can access their Netflix, Sky Go or similar subscription services when roaming in the EU. But the regulation will not really end geoblocking, warned the minority opposed to the regulation, as Pirate Party Member Julia Reda.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Copyright Policy, English, Europe, Information and Communications Technology/ Broadcasting, Regional Policy

US Renegotiation Of NAFTA To Include IP Rights, Digital Trade

18/05/2017 by Intellectual Property Watch 1 Comment

Newly confirmed United States Trade Representative Robert Lighthizer issued a letter to Congress today stating that he will lead a renegotiation of the 1994 North American Free Trade Agreement (NAFTA) with Canada and Mexico. And the changes will include new provisions on intellectual property rights and digital trade.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Copyright Policy, Enforcement, English, North America, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains

March-in Rights: A Lost Opportunity To Lower US Drug Prices

18/05/2017 by Steven Seidenberg for Intellectual Property Watch 17 Comments

It appears not just unfair, but absurdly so. The US government paid for research that produced a patented drug, the patents were licensed exclusively to a Japanese firm, and that firm is now committing price discrimination against the US. Astellas Pharma is selling its anti-prostate cancer drug, Xtandi, for over $129,000 per year per patient in the United States – triple the price of the drug in Japan. Alas, this situation is not unusual. Many drugs that were financed by US taxpayers are sold in the US at exorbitant prices, but are much cheaper in other high-income industrialized nations. This differential price problem could be solved easily. However, the US government has consistently refused to exercise its march-in rights in order to lower drug prices.

Filed Under: Features, IP Policies, Language, Themes, Venues, English, Health & IP, Health Policy Watch, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Perspectives on the US, Regional Policy

Major Research Funders, Institutions Pledge Transparency In Clinical Trials

18/05/2017 by Intellectual Property Watch Leave a Comment

More transparency on clinical trials is expected after major research funders, research institutions, and international health groups agreed that the research they fund or support will publicly release results of clinical trials.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Health & IP, Health Policy Watch, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

New Industry Alliance Aimed At Antimicrobial Resistance

18/05/2017 by Intellectual Property Watch Leave a Comment

Pharmaceutical industry representatives today announced a new alliance to fight antimicrobial resistance. The announcement came during a meeting of the private sector of the most advanced countries.

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, English, Europe, Health & IP, Health Policy Watch, Lobbying, Patents/Designs/Trade Secrets, Regional Policy

Attacks On WHO Candidate Are Defamatory, ‘Colonial’, Ambassador Says

17/05/2017 by Catherine Saez, Intellectual Property Watch 1 Comment

The African Union delegation to the United Nations came in outspoken numbers to a press briefing today to express unshakable support for the Ethiopian candidate to be the next head of the World Health Organization, Tedros Adhanom Ghebreyesus.

Filed Under: IP Policies, Language, Themes, Venues, Africa, English, Finance, Health & IP, Health Policy Watch, Lobbying, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains, WHA 2017, WHO

IFPMA Priorities At WHA: Election, Antibiotics, Cancer, Pandemics

17/05/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment

The new head of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has hit the ground running in Geneva, and is weighing in on a variety of policy issues, this week providing a list of priorities for the research-based pharma industry at the upcoming annual World Health Assembly.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Health & IP, Health Policy Watch, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, WHA 2017, WHO

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 9
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting